Add this topic to your myFT Digest for news straight to your inbox
Record shortages of common drugs have countries scrambling for alternatives while patients skip treatments
Justices’ scepticism towards disrupting the legal landscape is a potential boon for Republicans ahead of 2024 election
David Neal, sacked last month, says Home Office did not understand sector and left migrants open to exploitation
Transformative changes are still 10 to 15 years away, experts predict
Danish group seeks to branch out from diabetes and weight loss drugs with Cardior acquisition
Madrigal is the first to win approval for a treatment for a liver disease that affects one in 20
Shadow health secretary says that in the longer term, he would like no one to need to go private
Four years after lockdowns began we are still learning about pandemic hangovers
US award is latest problem for consumer group after disastrous baby formula acquisition
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
Lenmeldy gene therapy treats MLD, a condition that attacks the central nervous system of young children
There is an opportunity for local pharma groups, which Nomura says could take a fifth of the market by 2033
Ruth McKernan aims to make country a hub for research into the condition and accelerate development of new drugs
Acquisition gives pharmaceutical group mid-stage asset to challenge Novartis in new form of cancer care
WuXi AppTec’s business in America under threat by proposed national security legislation
One-year-old healthcare start-up gains investment from venture groups including General Catalyst and Andreessen Horowitz
Officials warn weaknesses in surveillance will hinder vaccine development as countries struggle to agree accord
Eli Lilly and Novo Nordisk’s weight-loss drugs have transformed their fortunes but a backlash could be looming
Worldwide study finds neurological conditions affect billions as life expectancy rises
Groups including Legal & General among those pushing for stricter health targets at world’s biggest food company
Retail group agrees first partnership with a big drug company since launching online pharmacy business in 2020
Booming sector raises tough questions for ESG investors
Industry regulator has shut 804 for-profit facilities since 2011, study shows
We risk forgetting the lessons of the Covid pandemic
International Edition